Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,137 | -10,877 | -7,667 | -32,279 | -28,455 |
| Depreciation Amortization | 1,774 | 990 | 392 | 1,863 | 1,418 |
| Accounts receivable | 361 | 862 | 868 | -1,810 | 698 |
| Other Working Capital | -5,877 | -4,907 | -2,693 | -5,781 | -1,218 |
| Other Operating Activity | -5,185 | -3,082 | -194 | 5,814 | 3,680 |
| Operating Cash Flow | $-25,064 | $-17,014 | $-9,294 | $-32,193 | $-23,877 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -536 | -432 | -81 | -1,204 | -1,077 |
| Net Acquisitions | 5 | 5 | N/A | N/A | N/A |
| Other Investing Activity | 4,400 | -400 | -200 | 0 | 0 |
| Investing Cash Flow | $3,869 | $-827 | $-281 | $-1,204 | $-1,077 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 27,000 | 27,000 | N/A | N/A | 0 |
| Debt Repayment | -22,292 | -22,292 | -2,485 | -2,692 | -210 |
| Common Stock Issued | 3,148 | 3,116 | 3,001 | 26,366 | 5,934 |
| Other Financing Activity | -2,069 | -1,998 | -184 | -1,482 | -64 |
| Financing Cash Flow | $5,787 | $5,826 | $332 | $22,192 | $5,660 |
| Exchange Rate Effect | -104 | -81 | -70 | N/A | 0 |
| Beginning Cash Position | 25,717 | 25,717 | 25,717 | 36,922 | 36,922 |
| End Cash Position | 10,205 | 13,621 | 16,404 | 25,717 | 17,628 |
| Net Cash Flow | $-15,512 | $-12,096 | $-9,313 | $-11,205 | $-19,294 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,064 | -17,014 | -9,294 | -32,193 | -23,877 |
| Capital Expenditure | -536 | -432 | -81 | -1,204 | -1,077 |
| Free Cash Flow | -25,600 | -17,446 | -9,375 | -33,397 | -24,954 |